These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30939040)
1. miR-132 Regulates Adriamycin Resistance in Colorectal Cancer Cells Through Targeting Extracellular Signal-Regulated Kinase 1. Liu Y; Zhang M Cancer Biother Radiopharm; 2019 Aug; 34(6):398-404. PubMed ID: 30939040 [No Abstract] [Full Text] [Related]
2. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells. Wang JJ; Yu JP Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176 [TBL] [Abstract][Full Text] [Related]
3. Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells. Zhang JY; Li YN; Mu X; Pan ZL; Liu WB Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8599-8608. PubMed ID: 30575899 [TBL] [Abstract][Full Text] [Related]
4. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance. Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556 [TBL] [Abstract][Full Text] [Related]
5. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance. Chen LZ; Ding Z; Zhang Y; He ST; Wang XH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147 [TBL] [Abstract][Full Text] [Related]
6. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin. Han GY; Cui JH; Liang S; Li HL Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance. Yuan LL; Li L; Liu JN; Mei J; Lei CJ Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821 [TBL] [Abstract][Full Text] [Related]
8. miR-107 Promotes Proliferation and Inhibits Apoptosis of Colon Cancer Cells by Targeting Prostate Apoptosis Response-4 (Par4). Liu F; Liu S; Ai F; Zhang D; Xiao Z; Nie X; Fu Y Oncol Res; 2017 Jul; 25(6):967-974. PubMed ID: 27938501 [TBL] [Abstract][Full Text] [Related]
9. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1. Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183 [TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells. Gao Z; Zhou H; Wang Y; Chen J; Ou Y J Cell Biochem; 2020 Jan; 121(1):332-343. PubMed ID: 31222825 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-126 is associated with colorectal cancer cells proliferation, migration and invasion by targeting IRS-1 via the AKT and ERK1/2 signaling pathways. Zhou Y; Feng X; Liu YL; Ye SC; Wang H; Tan WK; Tian T; Qiu YM; Luo HS PLoS One; 2013; 8(11):e81203. PubMed ID: 24312276 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway. Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558 [TBL] [Abstract][Full Text] [Related]
14. The microRNA-429/DUSP4 axis regulates the sensitivity of colorectal cancer cells to nintedanib. Cheng G; Li Y; Liu Z; Song X Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33495832 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
16. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity. Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111 [TBL] [Abstract][Full Text] [Related]
17. Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727 [TBL] [Abstract][Full Text] [Related]
18. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
19. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway. Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482 [TBL] [Abstract][Full Text] [Related]
20. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3. Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6478-6485. PubMed ID: 31378887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]